Background: Treatment guidelines recommend concomitantuse of ipratropium bromide and
inhaled β 2-agonists asseverity of COPD progresses. While the use of these two agents in …

Study objective To conduct a post hoc pharmacoeconomic evaluation of two double-blind,
randomized, prospective, parallel group studies comparing the long-term efficacy and safety …

Background Bronchodilators are commonly used as maintenance and rescue therapy in
patients with COPD. We aimed to examine the prescribing patterns of bronchodilators in …

The Global Obstructive Lung Disease (GOLD) guidelines suggest the potential use of
combination bronchodilator therapy in patients with stage II or higher chronic obstructive …

Chronic obstructive pulmonary disease (COPD) is a serious public health problem, due
largely to cigarette smoking. COPD is now the fourth-leading cause of death in the United …

Background The purpose of this analysis was to compare health care costs and utilization
among COPD patients who had long-acting beta-2 agonist (LABA) OR long-acting …

The incidence of chronic obstructive pulmonary disease (COPD) is rising in the United
States, and the disease represents a significant source of morbidity and mortality. Primary …

Study objective To document temporal usage trends for commonly used respiratory
medications in patients with COPD. Design We retrospectively evaluated baseline …

Objective Bronchodilators are routinely used in the long-term therapy of patients with COPD.
These drugs are generally evaluated for their short-term bronchodilatory effects. Long-term …

Bronchodilators are the mainstay of therapy for patients with established chronic obstructive
pulmonary disease (COPD) but, at present, the majority of patients use short-acting agents …